Restructuring and Recapitalizing Cannabis Companies
DENVER, CO., June 27, 2018 (GLOBE NEWSWIRE) -- VitaNova Inc., (OTC:GMVID) a Colorado corporation, completed a reverse merger with GlobalMin Ventures Inc. a publicly traded Nevada corporation, (“GlobalMin”), GlobalMin announced that it has received approval from FINRA for a name change from – GlobalMin Ventures Inc. (Ticker symbol GMVI to VetaNova Inc. (“VetaNova”) with a new ticker symbol (OTC:GMVID).
The name change will be effective at opening on June 27, 2018. The new symbol will be GMVID. The “D” will be removed in 20 business days and the symbol will change to VTNA. FINRA has also approved a one for 1,000 reverse split. The reverse split took effect June 27, 2018 at opening.
VetaNova was formed to identify and restructure cannabis related assets whose capitalization has been negatively impacted by the dramatic decline in cannabis prices in Colorado, Washington and Oregon. VetaNova also provides management and financial services to owners of cannabis related assets.
VetaNova’s directors and officers consist of John R. McKowen, CEO and Chairman of the Board, Jan McCaffrey and COO and director, John Ballard, director and Joe McKowen, director.
Forward-Looking Statements Disclosure:
This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Contacts: VitaNova Inc. John McKowen 303 248 6883 John@vtanva.com Jan McCaffrey 303 359 6018 Jan@vtanva.com
